Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. [PDF]
Luo R +6 more
europepmc +1 more source
Appropriate use of tissue sampling and somatostatin receptor PET imaging in the diagnosis of pancreatic neuroendocrine tumors: results of an International Delphi Consensus. [PDF]
Casey M +19 more
europepmc +1 more source
Somatostatin receptors in pituitary somatotroph adenomas as predictors of response to somatostatin receptor ligands: A pathologist's perspective. [PDF]
Botelho L +5 more
europepmc +1 more source
Structural basis for activation of somatostatin receptor 5 by cyclic neuropeptide agonists. [PDF]
Li J +9 more
europepmc +1 more source
Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy. [PDF]
Zhang S +9 more
europepmc +1 more source
Advances in the Oral Administration of Somatostatin Receptor Ligands in Acromegaly: A Systematic Review Focusing on Biochemical Response. [PDF]
Reverdiau C, Denimal D.
europepmc +1 more source
Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival. [PDF]
Perrone E +8 more
europepmc +1 more source
Detection of cardiac neuroendocrine tumour metastases by somatostatin receptor PET/CT: a systematic review and meta-analysis. [PDF]
Campanale D +5 more
europepmc +1 more source

